The Effects of Smoking in Patients in the Intensive Care Unit During the COVID-19 Pandemic.

IF 1 Q3 MEDICINE, GENERAL & INTERNAL
Medical Bulletin of Sisli Etfal Hospital Pub Date : 2023-12-29 eCollection Date: 2023-01-01 DOI:10.14744/SEMB.2023.22803
Seyhan Metin, Nermin Balta Basi, Sultan Acar Sevinc, Aysel Salkaya, Nurcan Coskun, Leyla Kilinc Turkoglu, Ayse Surhan Cinar, Sibel Oba, Haci Mustafa Ozdemir
{"title":"The Effects of Smoking in Patients in the Intensive Care Unit During the COVID-19 Pandemic.","authors":"Seyhan Metin, Nermin Balta Basi, Sultan Acar Sevinc, Aysel Salkaya, Nurcan Coskun, Leyla Kilinc Turkoglu, Ayse Surhan Cinar, Sibel Oba, Haci Mustafa Ozdemir","doi":"10.14744/SEMB.2023.22803","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>In this study, we aimed to see the effects of smoking prevalence, the length of stay regarding the usage of cigarettes, and the effects on the mortality of COVID-19 in our Intensive Care Unit (ICU).</p><p><strong>Methods: </strong>This is a retrospective single-centered study that was done in the ICU on patients with COVID-19 between 16th of March and 16<sup>th</sup> of May in 2020. The demographic data, comorbidity status, the units they were accepted from, clinical symptoms, respiratory support, prevalence of smoking, length of stay in the ICU, and mortalities of the patients were recorded. There were two groups: Smoker and non-smoker. There were 1100 COVID-19 patients and 150 of these were treated in ICU unit. 95 patient's data were accessed. Statistical analyses were performed with the Scientific Package for the Social Science (version 21.0; SPSS Inc.).</p><p><strong>Results: </strong>There were 69.4% non-smoker and 35.8% smoker, and 5.3% of the smoker did smoke before (Table 1). The average age of the patients in smoker group was less than nonsmoker. The incidence of chronic obstructive pulmonary disease was higher in smokers (Table 2). The most common symptom was cough and it was 82% in nonsmoker group and 76.5% in smoker group (Table 3). In both groups, respiratory support was provided by İMV (Table 4). There was no relationship between two groups according to age (p=0.044) and gender of patients (p:0.062) (Table 2). The length of ICU stay was 7.6 days for smoking patients in the ICU and 9.3 days for non-users. While the mortality was 52.9% for smokers, it was 39.3% for non-smokers. No statistical correlation was found between smoking status, length of stay in ICU, and survival (Fig. 1). Smoking is blamed among the factors that cause this aggressive process, which can progress to respiratory failure and result in mortality in COVID-19 disease.</p><p><strong>Conclusion: </strong>Some studies also claim that smoking can be protective. There is still no clarity on this issue. It was concluded that smoking has no effect on the duration of ICU stay and mortality in patients treated in the ICU with respiratory failure due to COVID-19 pneumonia.</p>","PeriodicalId":42218,"journal":{"name":"Medical Bulletin of Sisli Etfal Hospital","volume":"57 4","pages":"520-525"},"PeriodicalIF":1.0000,"publicationDate":"2023-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10805045/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Bulletin of Sisli Etfal Hospital","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14744/SEMB.2023.22803","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: In this study, we aimed to see the effects of smoking prevalence, the length of stay regarding the usage of cigarettes, and the effects on the mortality of COVID-19 in our Intensive Care Unit (ICU).

Methods: This is a retrospective single-centered study that was done in the ICU on patients with COVID-19 between 16th of March and 16th of May in 2020. The demographic data, comorbidity status, the units they were accepted from, clinical symptoms, respiratory support, prevalence of smoking, length of stay in the ICU, and mortalities of the patients were recorded. There were two groups: Smoker and non-smoker. There were 1100 COVID-19 patients and 150 of these were treated in ICU unit. 95 patient's data were accessed. Statistical analyses were performed with the Scientific Package for the Social Science (version 21.0; SPSS Inc.).

Results: There were 69.4% non-smoker and 35.8% smoker, and 5.3% of the smoker did smoke before (Table 1). The average age of the patients in smoker group was less than nonsmoker. The incidence of chronic obstructive pulmonary disease was higher in smokers (Table 2). The most common symptom was cough and it was 82% in nonsmoker group and 76.5% in smoker group (Table 3). In both groups, respiratory support was provided by İMV (Table 4). There was no relationship between two groups according to age (p=0.044) and gender of patients (p:0.062) (Table 2). The length of ICU stay was 7.6 days for smoking patients in the ICU and 9.3 days for non-users. While the mortality was 52.9% for smokers, it was 39.3% for non-smokers. No statistical correlation was found between smoking status, length of stay in ICU, and survival (Fig. 1). Smoking is blamed among the factors that cause this aggressive process, which can progress to respiratory failure and result in mortality in COVID-19 disease.

Conclusion: Some studies also claim that smoking can be protective. There is still no clarity on this issue. It was concluded that smoking has no effect on the duration of ICU stay and mortality in patients treated in the ICU with respiratory failure due to COVID-19 pneumonia.

COVID-19 大流行期间重症监护室患者吸烟的影响。
研究目的在这项研究中,我们旨在了解在重症监护病房(ICU)中吸烟率的影响、使用香烟的住院时间以及对 COVID-19 死亡率的影响:这是一项回顾性单中心研究,研究对象为 2020 年 3 月 16 日至 5 月 16 日期间在重症监护室中感染 COVID-19 的患者。研究记录了患者的人口统计学数据、合并症状况、接收单位、临床症状、呼吸支持、吸烟率、在重症监护室的住院时间和死亡率。研究分为两组:吸烟者和非吸烟者。共有 1100 名 COVID-19 患者,其中 150 人在重症监护室接受治疗。共获取了 95 名患者的数据。使用社会科学软件包(21.0 版;SPSS 公司)进行统计分析:非吸烟者占 69.4%,吸烟者占 35.8%,5.3% 的吸烟者以前吸烟(表 1)。吸烟组患者的平均年龄小于非吸烟者。吸烟者的慢性阻塞性肺病发病率较高(表 2)。最常见的症状是咳嗽,非吸烟组为 82%,吸烟组为 76.5%(表 3)。两组患者均使用 İMV 提供呼吸支持(表 4)。两组患者的年龄(P=0.044)和性别(P:0.062)没有关系(表 2)。吸烟患者在重症监护室的住院时间为 7.6 天,非吸烟患者为 9.3 天。吸烟者的死亡率为 52.9%,不吸烟者为 39.3%。吸烟状况、重症监护室住院时间和存活率之间没有统计学关联(图 1)。结论:吸烟是导致这种侵袭性过程的因素之一,它可发展为呼吸衰竭,并导致 COVID-19 疾病的死亡:结论:一些研究也声称吸烟具有保护作用。结论:一些研究还声称吸烟可以起到保护作用。结论:对于因 COVID-19 肺炎导致呼吸衰竭而在重症监护室接受治疗的患者,吸烟对重症监护室的住院时间和死亡率没有影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Medical Bulletin of Sisli Etfal Hospital
Medical Bulletin of Sisli Etfal Hospital MEDICINE, GENERAL & INTERNAL-
自引率
16.70%
发文量
41
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信